Concepedia

Publication | Open Access

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer

DOIFull Paper Access

41

Citations

32

References

2023

Year

Hao Zhang, Shuangli Zhu, Haiting Zhou, Rui Li, Xiaohui Xia, Huihua Xiong
Frontiers in Oncology

Abstract

MTHFD2 could be a crucial molecular biomarker for predicting patient prognosis and a novel therapeutic target in TNBC. In addition, MTHFD2 is a potential ferroptosis regulatory gene in TNBC.

References

YearCitations

Page 1